COVID-19 immunity lasts over 4 months, but antibody and T cells can “uncouple"
Majority carry neutralizing antibodies 16-18 weeks after mild or asymptomatic SARS-CoV-2 infection, but antibody and T cell responses can "uncouple".
2
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2
The first clinical efficacy results of ChAdOx1nCoV-19
Feature
Q&A: Cold chains, COVID-19 vaccines and reaching low-income countries
Many low-income countries lack the infrastructure to deliver vaccines effectively, so how can we ensure COVID-19 vaccines are accessible for all?
3
Vaccines give us light at end of the tunnel, Neil Ferguson tells Paris Forum
Imperial’s Professor Neil Ferguson says that the promise of effective COVID-19 vaccines is very encouraging but we may need restrictions until then.
‘Vaccines have saved more lives than any other medicines’- Robin Shattock
A top vaccine expert has tackled public concerns that a rapid rollout of COVID immunisation programme would be unsafe.
Robin Shattock says 'we could be living with COVID-19 for years to come'
Imperial’s COVID-19 vaccine lead, Professor Robin Shattock, has told MPs we could be living with the virus for years to come.
UK researchers to explore human challenge studies for COVID-19
Researchers are set to explore a human challenge study with the virus that causes COVID-19, the first such study anywhere in the world.
Imperial agree vaccine research and education collaboration with Indonesia
Imperial has agreed a pioneering research and education collaboration with Indonesia to advance vaccine development and help tackle COVID-19.
Robin Shattock tells MEPs of ‘promising’ vaccine progress
Professor Robin Shattock, the lead for Imperial's COVID-19 vaccine, updated the European Parliament today on the progress of his team's vaccine.
Landmark coronavirus study to trial inhaled Imperial and Oxford vaccines
A small clinical study will explore the effects of delivering the vaccines to the airways.
